The Dow Jones index closed higher by over 200 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
Catheter Precision
- The Trade: Catheter Precision, Inc. VTAK Director, Executive Chairman and CEO David A Jenkins acquired a total of 16,263 shares an average price of $0.39. To acquire these shares, it cost around $6,323.
- What’s Happening: Catheter Precision said its VIVO System was highlighted in a case study in EP Lab Digest.
- What Catheter Precision Does: Catheter Precision Inc Formerly Ra Medical Systems Inc is a commercial-stage medical device company whose business comprises of the design, manufacture and sale of new medical technologies in the field of cardiac electrophysiology, or EP.
ADM Endeavors
- The Trade: ADM Endeavors, Inc. ADMQ CEO Marc Johnson acquired a total of 1,100 shares at at an average price of $0.04. To acquire these shares, it cost around $45.10.
- What’s Happening: The company’s stock jumped around 38% over the past month.
- What ADM Endeavors Does: ADM Endeavors Inc operates a diverse vertical integrated business, which consists of a retail sales division, focusing on screen print promotions, embroidery production, digital production, import wholesale sourcing, and uniforms.
Check This Out: SLB, Travelers Companies And 3 Stocks To Watch Heading Into Friday
Tilray Brands
- The Trade: Tilray Brands, Inc. TLRY Chief Strategy Officer Denise M Faltischek acquired a total of 10,000 shares at an average price of $2.05. The insider spent around $20,500 to buy those shares.
- What’s Happening: According to an SEC filing, Tilray entered into an assignment and assumption agreement with Double Diamond Holdings Ltd. (DDH) on Jan. 9.
- What Tilray Brands Does: Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray.
Don’t forget to check out our premarket coverage here
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.